Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Sarcoma × Leukapheresis × Clear all

Phase

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Glioblastoma 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Sarcoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Large Granular Lymphocytic 1 Leukemia, Hairy Cell 1 Immunoblastic Lymphadenopathy 1 Hematologic Neoplasms 1 Glioma 1 Breast Neoplasms 1

Interventions

Doxorubicin 13 Cyclophosphamide 9 Gemcitabine 8 Filgrastim 8 Ifosfamide 7 Cisplatin 7 pazopanib 6 Radiotherapy 6 Docetaxel 6 Radiation 5 Irinotecan 5 Granulocyte Colony-Stimulating Factor 5 Etoposide 5 Trabectedin 4 Magnetic Resonance Spectroscopy 4 Celecoxib 4 Busulfan 4 sargramostim 3 X-Rays 3 Radiotherapy, Intensity-Modulated 3 Neoadjuvant Therapy 3 Dexrazoxane 3 Cryosurgery 3 Blotting, Western 3 temsirolimus 2 pembrolizumab 2 ixabepilone 2 ganitumab 2 fluoromisonidazole 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03240861 2023-11-01

NYESO SCT

Jonsson Comprehensive Cancer Center

Phase 1 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡